You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
ICU-CARE: An interactive mobile app to enhance the efficiency of daily informal caregiving in the intensive care unit
SBC: SILICON CURES LLC Topic: NINRPROJECT SUMMARY Actively involving informal caregivers in direct patient care at the bedside in the intensive care unit (ICU) has the potential to improve patient, informal caregiver, and health care system outcomes. Practice guidelines call for the liberal inclusion of informal caregivers as active partners in ICU care, but there is a critical, unmet need to develop tools that effectively operati ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Deep-UV Microscopy for Real-Time Adequacy Analysis of Bone Marrow Aspirates
SBC: Cellia Science, Inc. Topic: NIBIBProject Summary/Abstract Bone marrow aspirates are critical to the diagnosis, staging, and monitoring of hematologic conditions and cancers (e.g., leukemia, aplastic anemia, sickle cell disease, and metastasis of solid tumors), but 8-50% of aspirations are unsuccessful due to operator technique, hemodilution, or underlying pathology. Because this process is manual and error-prone, there is an oppo ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Tumor Antigen Targeted Nanoparticle Therapy for Glioblastoma (GBM)
SBC: NANOVALENT PHARMACEUTICALS INC Topic: 102Project Summary The goal of this Fast Track STTR project is to determine proof-of-principle and efficacy of a novel blood brain barrier (BBB) penetrating therapeutic nanoparticle for the potential treatment of otherwise intractable brain tumors like glioblastoma multiforme (GBM). This project seeks to demonstrate that novel, targetable nanoparticles can delivery therapeutic substances to human bra ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Microwave-Enhanced Microreactor for Ultrafast Detection of Protein Biomarkers
SBC: VIC FOUNDRY INC Topic: 400Project Summary In diagnosis, risk stratification, and management of life-threatening diseases/conditions, every minute counts and unambiguous detection of many relevant protein biomarkers is crucial. Unfortunately, the workflow of current unambiguous approach–mass spectrometry–is bottlenecked by the sample preparation process. A microwave-enhanced, flow-through microreactor is proposed here f ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Novel therapeutic target to combat cutaneous lupus
SBC: DERMAXON LLC Topic: NCATSProject Summary / Abstract: Chronic auto-inflammatory skin diseases such as cutaneous lupus erythematosus (CLE) affect millions of Americans with limited therapeutic options currently available, creating a significant need for novel therapeutic options. A hallmark of CLE is the presence of autoantibodies against nucleic acids and nucleic acid-binding proteins, as well as elevated interferons (IFNs ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Development of a Targeted Radiotherapeuitc for Pancreatic Ductal Adenocarcinoma
SBC: ADDUCTNE LLC Topic: 102In 2020 alone, pancreatic cancer is estimated to have resulted in 47,050 deaths in the U.S. making it the fourth leading cause of cancer-related death. Pancreatic ductal adenocarcinoma (PDAC) makes up greater than 90% of all pancreatic cancer diagnoses and has an overall five-year survival rate of just 10%. New therapeutic options are needed to improve the poor prognosis for patients with PDAC. Ex ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Development of a Precision Medicine-based Diagnostic Tool for Membranous Nephropathy
SBC: Nephropathology Associates, PLC Topic: 300Summary/Abstract The goal of this project is to develop a precision medicine approach to the rapid diagnosis of membranous nephropathy (MN) using automated statistical analysis of proteomic data obtained from kidney biopsies. This approach uses data-independent acquisition mass spectrometry (DIA-MS) and an algorithmic data pipeline capable of efficiently determining the most likely MN antigen type ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Clinical Cytophone platform for detection of circulating melanoma cells.
SBC: CytoAstra, LLC Topic: NCIMost patients with melanoma die from metastatic disease as the result of circulating tumor cells (CTCs) spreading from a primary tumor through the blood to vital organs. Despite significant progress in the development of in vitro CTC-detection assays, they still have low sensitivity due to the small samples of blood taken. To overcome these problems, we developed in vivo photoacoustic (PA) flow cy ...
STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health -
Antioxidant enzyme-loaded Pro-NP for treatment of TBI.
SBC: PROTRANSIT NANOTHERAPY LLC Topic: 106ABSTRACT Traumatic brain injury (TBI) is one of the leading causes of death and disability worldwide and comes with a significant economic burden associated with emergency room visits and hospitalizations. Oxidative stress- mediated secondary injury post-TBI is a considerable risk factor for mortality and long-term impairment. Immediately following TBI, a cascade of biological responses leads to i ...
STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health -
An Economical Point-of-Care Software Solution Prototype for Medication Prior Authorization
SBC: Breezmed Topic: 104ABSTRACT This STTR Phase I project uses mixed-method formative evaluation strategies to develop, test, and evaluate an alpha prototype of Breezmed, a point-of-care electronic prior authorization web-based platform. Prior authorization burdens the current medical system, hampering a provider’s ability to efficiently prescribe medication and in a timely fashion. This often leads to treatment non-c ...
STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health